Animal Vaccines Market Poised for Growth with Rising Demand for Pet Insurance and Animal Health Expenditure

The global animal vaccines market size was USD 13.90 Billion in 2022 and is expected to register a revenue CAGR of 9.7% during the forecast period. The global animal vaccines market is projected to see significant growth, fueled by rising demand for pet insurance, increased animal health expenditures, and the rising prevalence of animal diseases. Vaccines are critical tools for safeguarding animal health, playing an essential role in preventing the spread of infectious diseases in livestock and companion animals alike. The market is also benefiting from increased awareness of the value of vaccines in securing the health of animals that are part of the global food supply chain, as well as in protecting public health against zoonotic diseases.

Market Drivers: Increased Animal Health Expenditure and Adoption of Ruminant Vaccines

Animal health expenditures are increasing as pet ownership and livestock farming grow, leading to higher demand for vaccines. Merck Animal Health recently received a positive opinion from the European Medicines Agency for BRAVECTO, a vaccine aimed at improving canine health. The growing need to protect cattle from diseases and boost global livestock production is driving the adoption of ruminant vaccines, particularly as cattle remain a primary source of meat, milk, and other products. Vaccines for diseases like rabies, equine influenza, and foot-and-mouth disease are widely used, playing a critical role in the protection of livestock and safeguarding animal-derived products.

The role of animal vaccines in enhancing well-being is underscored by their ability to elicit a strong immune response, similar to natural immunity. These vaccines help prevent the spread of infectious agents, maintaining the safety and quality of animal products. As demand for livestock products increases globally, so does the need for vaccinations that can help ensure the health and safety of the animals involved.

Get | Download Sample Copy with TOC, Graphs & List of Figures@ https://www.emergenresearch.com/request-sample/2807

Population Growth and Global Trade Amplify Demand for Vaccines

As human and animal populations grow, along with increasing environmental degradation and global interconnectedness, the risk of disease transmission across species also rises. The global demand for animal protein has spurred increased production of commercial food animals, elevating the importance of vaccines to manage and control emerging health threats. Notably, animal vaccines have become a key component in combating zoonotic diseases, which can impact both livestock and companion animals and pose significant risks to public health.

Market Restraints: Concerns Over Adverse Effects of Veterinary Vaccines

Despite the benefits, some concerns remain over the potential adverse impacts of veterinary vaccines on both human and animal health. The United Kingdom is addressing this challenge by investing in the U.K. Animal Vaccine Manufacturing and Innovation Centre in Surrey, a project funded jointly by the U.K. government and the Bill & Melinda Gates Foundation. This initiative aims to accelerate the development of livestock vaccines to fight viral diseases, such as coronaviruses in animals.

Product and Type Segmentation: Attenuated Live Vaccines Lead, Livestock Segment Dominates

The animal vaccines market is segmented by product type, with the attenuated live vaccines category leading due to its long-standing use and strong immune response capabilities. These vaccines are particularly effective in creating lasting immunity, reducing the need for booster doses, and offering convenient administration methods like oral delivery. The livestock segment also holds a dominant share of the market, supported by growing global livestock populations and government funding aimed at tackling livestock diseases.

The companion animal segment, covering vaccines for pets like dogs and ferrets, is expected to see rapid growth. Canine distemper, for example, is a viral disease that affects multiple animal species, requiring vaccination to prevent respiratory and gastrointestinal complications, especially in puppies and immunocompromised dogs.

Route of Administration: Subcutaneous Segment Shows Strong Market Performance

Subcutaneous administration of animal vaccines is a common practice, particularly because of its simplicity, low discomfort levels, and slow drug absorption rate. Commonly used injection sites for animals include the areas behind the shoulders and neck. Other routes, such as intramuscular administration, are also widely used, although subcutaneous injections are often preferred by veterinarians for their ease of use and the relative comfort they provide animals.

As the animal vaccines market continues to expand, key players are focusing on innovative approaches to improve the safety, efficacy, and accessibility of animal vaccines globally. With ongoing developments and rising public and private investments in animal health, the future of the animal vaccines market looks promising as it addresses the growing challenges of disease prevention and food safety across the world.

For More Details On this Report: @ https://www.emergenresearch.com/industry-report/animal-vaccines-market

Animal Vaccines Top Companies and Competitive Landscape

The global animal vaccines market is fairly fragmented with many large and medium-sized players accounting for the majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, and developing, testing, and introducing more effective animal vaccines solutions.

Some major players included in the global animal vaccines market report are:

Zoetis

Virbac

Elanco

Merck & Co., Inc.

Ceva Santé Animale

Boehringer Ingelheim International GmbH

Phibro Animal Health Corporation

IDEXX

HESTER BIOSCIENCES LIMITED

Indian Immunologicals Ltd.

Animal Vaccines Latest Industry Updates

In September 2022, Zoetis acquired Jurox, a privately held animal health company that develops, manufactures, and markets a wide range of veterinary medicines for treating livestock and companion animals.

In June 2022, Boehringer Ingelheim and CarthroniX partnered to pursue small-molecule therapeutics in canine oncology.

In July 2021, Elanco acquired Kindred Bio, a biopharmaceutical company focused on developing novel pet therapeutics.

Animal Vaccines Market Segmentation Analysis

For the purpose of this report, Emergen Research has segmented the global animal vaccines market on the basis of product, type, route of administration, and region:

Product Outlook (Revenue, USD Billion; 2019-2032)

Attenuated live vaccines

Inactivated vaccines

Subunit vaccines

DNA vaccines

Recombinant vaccines

Type Outlook (Revenue, USD Billion; 2019-2032)

Livestock

Companion

Route of Administration Outlook (Revenue, USD Billion; 2019-2032)

Subcutaneous

Intramuscular

Intranasal

Regional Outlook (Revenue, USD Billion; 2019-2032)

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Spain

Benelux

Russia

Rest of Europe

Asia Pacific

China

Japan

South Korea

India

ASEAN Countries

Oceania

Rest of APAC

Latin America

Brazil

Mexico

Rest of LATAM

Middle East & Africa

GCC Countries

Israel

Turkey

South Africa Rest of MEA

Click here to Get customization @ https://www.emergenresearch.com/request-for-customization/2807

Navigating the Industry Landscape: Key Findings and Recommendations

Animal Vaccines Market Size @ https://www.emergenresearch.com/industry-report/animal-vaccines-market/market-size

Animal Vaccines Market Share @ https://www.emergenresearch.com/industry-report/animal-vaccines-market/market-share

Animal Vaccines Market Trends @ https://www.emergenresearch.com/industry-report/animal-vaccines-market/market-trends

Animal Vaccines Regional Market Demand @ https://www.emergenresearch.com/industry-report/animal-vaccines-market/regional-market-demand

Animal Vaccines Market Analysis @ https://www.emergenresearch.com/industry-report/animal-vaccines-market/market-analysis

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.